Functional modulation of human delta opioid receptor by neuropeptide FF

BMC Neuroscience

Volumn 6, Issue , 2005, Pages

  Änkö, Minna Liisa ^a   Panula, Pertti ^a,b  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIC AMP; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DELTORPHIN; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; NEUROPEPTIDE; NEUROPEPTIDE FF; OPIATE RECEPTOR; PROTEIN DERIVATIVE; TERBIUM; NARCOTIC ANALGESIC AGENT; OLIGOPEPTIDE; PHENYLALANYL LEUCYL PHENYLALANYL GLUTAMINYL PROLYL GLUTAMINYL ARGINYL PHENYLALANINAMIDE; PHENYLALANYL-LEUCYL-PHENYLALANYL-GLUTAMINYL-PROLYL-GLUTAMINYL-ARGINYL-PHENYLALANINAMIDE;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BINDING SITE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL DESIGN; EXPRESSED SEQUENCE TAG; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; HAMSTER; METABOLISM; PHYSIOLOGY; PROTEIN BINDING;

ANALGESICS, OPIOID; ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; HUMANS; MICE; OLIGOPEPTIDES; PROTEIN BINDING; RECEPTORS, OPIOID, DELTA;

EID: 26444556512     PISSN: 14712202     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-6-21     Document Type: Article

References (47)

1. Yang H-YT, Fratta W, Majane EA, Costa E: Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci U S A 1985, 82:7757-7761.
2. Perry SJ, Yi-Kung Huang E, Cronk D, Bagust J, Sharma R, Walker RJ, Wilson S, Burke JF: A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 1997, 409:426-430.
3. Vilim FS, Aarnisalo AA, Nieminen M-L, Lintunen M, Karlstedt K, Kontinen VK, Kalso E, States B, Panula P, Ziff E: Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 1999, 55:804-811.
4. Gouarderes C, Jhamandas K, Sutak M, Zajac JM: Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br J Pharmacol 1996, 117:493-501.
5. Malin DH, Lake JR, Fowler DE: FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 1990, 11:227-280.
6. Allard M, Labrouche S, Nosjean A, Laguzzi R: Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat. J Pharmacol Exp Ther 1996, 274:577-583.
7. Majane EA, Yang HY: FMRF-NH2-like peptide is deficient in the pituitary gland of the Brattleboro rat. Peptides 1990, 11:345-349.
8. Panula P, Kalso E, Nieminen M, Kontinen VK, Brandt A, Pertovaara A: Neuropeptide FF and modulation of pain. Brain Res 1999, 848:191-196.
9. Kivipelto L, Panula P: Origin and distribution of neuropeptide-FF-like immunoreactivity in the spinal cord of rats. J Comp Neurol 1991, 307:107-119.
10. Majane EA, Panula P, Yang HY: Rat brain regional distribution and spinal cord neuronal pathway of FLFQPQRF-NH2, a mammalian FMRF-NH2-like peptide. Brain Res 1989, 494:1-12.
11. Arvidsson U, Dado RJ, Riedl M, Lee JH, Law PY, Loh HH, Elde R, Wessendorf MW: Delta-opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 1995, 15:1215-1235.
12. Chen X, Zidichouski JA, Harris KH, Jhamandas JH: Synaptic actions of neuropeptide FF in the rat parabrachial nucleus: interactions with opioid receptors. J Neurophysiol 2000, 84:744-751.
13. Quelven I, Roussin A, Zajac JM: Functional consequences of neuropeptide FF receptors stimulation in mouse: a cerebral glucose uptake study. Neuroscience 2004, 126:441-449.
14. Wei H, Panula P, Pertovaara A: A differential modulation of allodynia, hyperalgesia and nociception by neuropeptide FF in the periaqueductal gray of neuropathic rats: interactions with morphine and naloxone. Neuroscience 1998, 86:311-319.
15. Altier N, Dray A, Menard D, Henry JL: Neuropeptide FF attenuates allodynia in models of chronic inflammation and neuropathy following intrathecal or intracerebroventricular administration. Eur J Pharmacol 2000, 407:1468-1474.
16. Allard M, Jordan D, Zajac JM, Ries C, Martin D, Monkounga D, Kopp N, Simonnet G: Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res 1994, 633:127-132.
17. Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, Durkin MM, Smith KE, Tamm JA, Boteju LW, Lakhlani PP, Raddatz R, Yoa W-J, Ogozalek KL, Boyle N, Kouranova EV, Quan Y, Vaysse PJ, Wetzel JM, Branchek TA, Gerald C, Borowsky B: Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 2000, 275:39324-31.
18. Hinuma S, Shintani Y, Fukusumi S, Iijima N, Matsumoto Y, Hosoya M, Fujii R, Watanabe T, Kikuchi K, Terao Y, Yano T, Yamamoto T, Kawamata Y, Habata Y, Asada M, Kitada C, Kurokawa T, Onda H, Nishimura O, Tanaka M, Ibata Y, Fujino M: New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol 2000, 2:703-708.
19. Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmitdt DB, Buckley PT, Dytko GM, Murdock PR, Tan KB, Shabon U, Nuthulaganti P, Wang DY, Wilson S, Bergsma DJ, Sarau HM: Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J Biol Chem 2000, 275:25965-25971.
20. Zeng Z, McDonald TP, Wang R, Liu Q, Austin CP: Neuropeptide FF receptor 2 (NPFF2) is localized to pain-processing regions in the primate spinal cord and the lower level of the medulla oblongata. J Chem Neuroanat 2003, 25:269-278.
21. Engstrom MT, Brandt A, Wurster S, Savola JM, Panula P: Prolactin Releasing Peptide Has High Affinity and Efficacy at Neuropeptide FF2 Receptors. J Pharmacol Exp Ther 2003, 305:825-832.
22. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH: Cloning of a delta opioid receptor by functional expression. Science 1992, 258:1952-1955.
23. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG: The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 1992, 89:12048-12052.
24. McKenzie FR, Milligan G: Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2. Biochem J 1990, 267:391-398.
25. Fukuda K, Kato S, Morikawa H, Shoda T, Mori K: Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem 1996, 67:1309-1316.
26. Piros ET, Charles AC, Song L, Evans CJ, Hales TG: Cloned delta-opioid receptors in GH(3) cells inhibit spontaneous Ca(2+) oscillations and prolactin release through K(IR) channel activation. J Neurophysiol 2000, 83:2691-2698.
27. Tsu RC, Chan JSC, Wong YH: Regulation of multiple effectors by the cloned delta-opioid receptor: stimulation of phospholipase C and type II adenylyl cyclase. J Neurochem 1995, 64:2700-2707.
28. van Biesen T, Luttrell LM, Hawes BE, Lefkowitz RJ: Mitogenic signaling via G protein-coupled receptors. Endocr Rev 1996, 17:698-714.
29. Stewart PE, Hammond DL: Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J Pharmacol Exp Ther 1994, 268:701-708.
30. Rapaka RS, Porreca F: Development of delta opioid peptides as nonaddicting analgesics. Pharmacol Res 1991, 8:1-8.
31. Hasbi A, Allouche S, Sichel F, Stanasila L, Massotte D, Landemore G, Polastron J, Jauzac P: Internalization and recycling of delta-opioid receptor are dependent on a phosphorylation-dephosphorylation mechanism. J Pharmacol Exp Ther 2000, 293:237-247.
32. Trapaidze N, Gomes I., Cvejic S, Bansinath M, Devi LA: Opioid receptor endocytosis and activation of MAP kinase pathway. Brain Res Mol Brain Res 1999, 76:220-228.
33. Tsao PI, von Zastrow M: Type-specific sorting of G protein-coupled receptors after endocytosis. J Biol Chem 2000, 275:11130-11140.
34. Law PY, Hom DS, Loh HH: Opiate regulation of adenosine 3′:5′-cyclic monophosphate level in neuroblastoma X glioma NG108-15 hybrid cells. Relationship between receptor occupancy and effect. Mol Pharmacol 1983, 23:26-35.
35. Sim LJ, Selley DE, Xiao R, Childers SR: Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum. Eur J Pharmacol 1996, 307:97-105.
36. Petäjä-Repo UE, Hogue M, Laperrière A, Walker P, Bouvier M: Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. J Biol Chem 2000, 275:13727-13736.
37. Christopoulos A, Kenakin T: G protein-coupled receptor allosterism and complexing. Pharmacol Rev 2002, 54:323-374.
38. 1 adenosine receptor coupling to G proteins. Biochim Biophys Acta 1995, 1265:15-21.
39. Fawzi AB, MacDonald D, Benbow LL, Smith-Torhan A, Zhang H, Weig BC, Ho G, Tulshian D, Linder ME, Graziano MP: SCH-202676: An allosteric modulator of both agonist and antagonist binding to G protein-coupled receptors. Mol Pharmacol 2001, 59:30-37.
40. Jensen AA, Spalding TA: Allosteric modulation of G-protein coupled receptors. Eur J Pharm Sci 2004, 21:407-420.
41. Aarnisalo AA, Tuominen RK, Nieminen M, Vainio P, Panula P: Evidence for prolactin releasing activity in the rats. Neuroendocrinol Lett 1997, 18:191-196.
42. Cvejic S, Devi LA: Dimerization of the delta opioid receptor. J Biol Chem 1997, 272:26959-26964.
43. Bai M: Dimerization of G-protein-coupled receptors: roles in signal transduction. Cell Signal 2004, 16:175-186.
44. Xu M, Kontinen VK, Panula P, Kalso E: Effects of (1DMe)NPYF, a synthetic neuropeptide FF analogue, in different pain models. Peptides 1999, 20:1211-1217.
45. Petäjä-Repo UE, Hogue M, Bhalla S, Laperrière J-PM, Bouvier M: Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J 2002, 21:1628-1637.
46. Cahill CM, Morinville A, Hoffert C, O'Donnell D, Beaudet A: Upregulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 2003, 101:199-208.
47. Martin M, Matifas A, Maldonado R, Kieffer BL: Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones. Eur J Neurosci 2003, 17:701-708.